Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
about
Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies - Past, Present, and FutureWithdrawal of anticancer therapy in advanced disease: a systematic literature reviewFamilial risk for lung cancerIdentification of Distinct Psychosis Biotypes Using Brain-Based BiomarkersExpansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model.Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for ImmunotherapyMechanisms of resistance to EGFR tyrosine kinase inhibitors.Characterization of different CTC subpopulations in non-small cell lung cancer.Women and lung cancer: what is new?Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy.Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer.Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.Use of single chain antibody derivatives for targeted drug delivery.Is T790M mutation the key in development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)?p-Benzoquinone initiates non-invasive urothelial cancer through aberrant tyrosine phosphorylation of EGFR, MAP kinase activation and cell cycle deregulation: Prevention by vitamin C.Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.Examined lymph node count in non-small-cell lung cancer: will it be a decision making approach in treatment of NSCLC?Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter.Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.Academic medical centers as innovation ecosystems to address population -omics challenges in precision medicine.Antitumor Effect of Calcium-Mediated Destabilization of Epithelial Growth Factor Receptor on Non-Small Cell Lung Carcinoma.Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab.YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in non‑small cell lung cancer cells.Influence of estrogen in non-small cell lung cancer and its clinical implications.Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitroImportance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNATunable structure priors for Bayesian rule learning for knowledge integrated biomarker discovery
P2860
Q24564024-90DF5528-5152-49F9-B634-405472220460Q26777486-778DC61B-78DC-45FA-8B9D-0F571B6F25BDQ29249088-22C2DB83-3262-4F1E-9253-7EBF4025A5C9Q30363008-E7D71D1A-3B3E-4711-81F5-D7558D90B767Q35068046-C80D1835-B3B6-4996-8136-FD4CB5638FD3Q35623476-B202EFC1-4FC0-4313-9893-A09BD11978D6Q36238664-E127DB0F-7AA4-459A-A261-42AD72BA929BQ37005619-E9AFDB4E-4421-4294-958C-8A74FF090440Q37307499-0CEA721F-6D91-4E54-9C89-84C2C7AD16DAQ37581193-6C9F7320-9713-472D-96DD-CFCD4E698909Q37613341-77AC3C14-6382-46F3-8276-CCA990A5AEB2Q38837187-CF6E58FB-812C-49C6-9D90-F984D8BE60BFQ38850046-E58358C3-CC68-4D41-92ED-835894A35B01Q40341970-30DE09DC-E2DF-4A90-A7C8-65093C8C7F91Q41678957-9616B896-55F2-4F4A-AF11-DCF87175F9D7Q42290198-9F9AAC4C-D3F5-45E4-BCAA-3971EFC51C04Q42340620-C437E6BB-11F0-45E1-AA7B-0F7BC21E809EQ42593919-FF131992-535B-43E4-9B5E-C3B3D6087986Q47130842-B311D204-F79D-4BD4-BBDE-0863A68208D8Q49952999-2A358125-ACDC-4413-9A84-BF943EF775E7Q49962868-105DF3A9-3276-46AF-82A3-C061327DED37Q52594220-6E425E13-323B-4F45-9290-DA38A47F3729Q52649596-C46BA16F-BBB4-4D1C-B931-17C8075FA636Q53686708-9E1049A2-72D3-4CBA-A417-D5B1BAB5523BQ54979307-71144C09-9828-4C4E-BBB1-CA362C0E4290Q54981518-C8062F68-786D-4350-8DAF-4466C21703B0Q55460041-0B1B9B5E-7C24-4BA8-AE95-ABC39798A6C3Q57075013-1B100A9D-9A40-40A9-9A88-F5CC344EBDB3Q57786820-924C5333-995D-45ED-BBDF-E094EC8EB3A9Q58617557-791F9A23-0F77-4380-B304-DA40E0675ACCQ58739967-95AF3A0A-333F-45BF-B1B7-94E00CB456C4
P2860
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@ast
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@en
type
label
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@ast
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@en
prefLabel
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@ast
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@en
P2093
P2860
P1476
Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
@en
P2093
Drew Bethune
Gillian Bethune
Neale Ridgway
Zhaolin Xu
P2860
P577
2010-03-01T00:00:00Z